Sinopharm Announces Changes to Board Committee Composition Effective 18 August 2026

Bulletin Express

Aug 18

Sinopharm Group Co. Ltd. disclosed board-level adjustments that will take effect on 18 August 2026:

• Strategy and Investment Committee – Executive Director Yang Binghua joins as a member, expanding executive participation in the Company’s strategic planning body.

• Audit Committee – Non-executive Directors Zu Jing and Wen Deyong have been appointed members, strengthening oversight of financial reporting and internal control.

• Nomination Committee – Non-executive Director Li Ying becomes a member, adding depth to director selection and succession planning deliberations.

• Legal, Compliance and ESG Committee – Non-executive Director Xing Yonggang joins as a member, enhancing governance and sustainability supervision.

Following these changes, Sinopharm’s board consists of 2 executive directors, 7 non-executive directors and 5 independent non-executive directors. Chairman Jin Bin issued the announcement from Shanghai on 18 August 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1128722250"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1128722250\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1128722250?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-18 18:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1128722250","market":"hk","top_or_hot":-1,"title":"Sinopharm Announces Changes to Board Committee Composition Effective 18 August 2026","media":"Bulletin Express","content":"<p>Sinopharm Group Co. Ltd. disclosed board-level adjustments that will take effect on 18 August 2026:</p>\n<p>• Strategy and Investment Committee – Executive Director Yang Binghua joins as a member, expanding executive participation in the Company’s strategic planning body.</p>\n<p>• Audit Committee – Non-executive Directors Zu Jing and Wen Deyong have been appointed members, strengthening oversight of financial reporting and internal control.</p>\n<p>• Nomination Committee – Non-executive Director Li Ying becomes a member, adding depth to director selection and succession planning deliberations.</p>\n<p>• Legal, Compliance and ESG Committee – Non-executive Director Xing Yonggang joins as a member, enhancing governance and sustainability supervision.</p>\n<p>Following these changes, Sinopharm’s board consists of 2 executive directors, 7 non-executive directors and 5 independent non-executive directors. Chairman Jin Bin issued the announcement from Shanghai on 18 August 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sinopharm Announces Changes to Board Committee Composition Effective 18 August 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSinopharm Announces Changes to Board Committee Composition Effective 18 August 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-18 18:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sinopharm Group Co. Ltd. disclosed board-level adjustments that will take effect on 18 August 2026:</p>\n<p>• Strategy and Investment Committee – Executive Director Yang Binghua joins as a member, expanding executive participation in the Company’s strategic planning body.</p>\n<p>• Audit Committee – Non-executive Directors Zu Jing and Wen Deyong have been appointed members, strengthening oversight of financial reporting and internal control.</p>\n<p>• Nomination Committee – Non-executive Director Li Ying becomes a member, adding depth to director selection and succession planning deliberations.</p>\n<p>• Legal, Compliance and ESG Committee – Non-executive Director Xing Yonggang joins as a member, enhancing governance and sustainability supervision.</p>\n<p>Following these changes, Sinopharm’s board consists of 2 executive directors, 7 non-executive directors and 5 independent non-executive directors. Chairman Jin Bin issued the announcement from Shanghai on 18 August 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01099","symbol_name":"国药控股","start_time":0,"source_url":"","article_id":"1128722250","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1128722250","pubTimestamp":1787050020,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sinopharm Group Co. Ltd. disclosed board-level adjustments that will take effect on 18 August 2026: • Strategy and Investment Committee – Executive Director Yang Binghua joins as a member, expanding...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01099":"国药控股"},"translate_title":"国药控股宣布董事会委员会组成变更，自2026年8月18日起生效","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01099":1},"content_text":"Sinopharm Group Co. Ltd. disclosed board-level adjustments that will take effect on 18 August 2026:\n• Strategy and Investment Committee – Executive Director Yang Binghua joins as a member, expanding executive participation in the Company’s strategic planning body.\n• Audit Committee – Non-executive Directors Zu Jing and Wen Deyong have been appointed members, strengthening oversight of financial reporting and internal control.\n• Nomination Committee – Non-executive Director Li Ying becomes a member, adding depth to director selection and succession planning deliberations.\n• Legal, Compliance and ESG Committee – Non-executive Director Xing Yonggang joins as a member, enhancing governance and sustainability supervision.\nFollowing these changes, Sinopharm’s board consists of 2 executive directors, 7 non-executive directors and 5 independent non-executive directors. Chairman Jin Bin issued the announcement from Shanghai on 18 August 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}